Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Bleeker

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2015
Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell CarcinomaMichael P Gustafson, Yi Lin, Jonathan S Bleeker, et al.
Surgery Open Science|September 21, 2020
Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology programJonathan S Bleeker, Christopher J Sumey, Steven F Powell, et al.
JCO Precision Oncology|February 9, 2022
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational StudySteven F Powell, Elie G Dib, Jonathan S Bleeker, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2015
Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell CarcinomaMichael P Gustafson, Yi Lin, Jonathan S Bleeker, et al.
Surgery Open Science|September 21, 2020
Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology programJonathan S Bleeker, Christopher J Sumey, Steven F Powell, et al.
JCO Precision Oncology|February 9, 2022
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational StudySteven F Powell, Elie G Dib, Jonathan S Bleeker, et al.
Pageof 2